5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6- phosphatase

Diabetes

Volumn 49, Issue 6, 2000, Pages 896-903

  Lochhead, Pamela A ^c   Salt, Ian P ^a   Walker, Kay S ^c   Hardie, D Grahame ^c   Sutherland, Calum ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; BETA ACTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOPHILIN; DEXAMETHASONE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INSULIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; HEPATOMA CELL; HYPERGLYCEMIA; LIVER METABOLISM; MOLECULAR MIMICRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT;

EID: 0034074153     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.6.896     Document Type: Article

References (71)

1. O'Brien RM, Granner DK: Regulation of gene expression by insulin. Physiol Rev 76:1109-1161, 1996
2. O'Brien RM, Granner DK: PEPCK gene as a model of inhibitory effects of insulin on gene transcription. Diabetes Care 13:327-339, 1990
3. Friedman JE, Sun Y, Ishizuka T, Farrell CJ, McCormack SE, Herron LM, Hakimi P, Lechner P, Yun JS: PEPCK gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J Biol Chem 272:31475-31481, 1997
4. Wang J-C, Stromstedt P-E, O'Brien RM, Granner DK: Hepatic nuclear factor 3 is an accessory factor required for the stimulation of PEPCK gene transcription by glucocorticoids. Mol Endocrinol 10:794-800, 1996
5. Sutherland C, O'Brien RM, Granner DK: New connections in the regulation of PEPCK gene expression by insulin. Philos Trans P Soc Lond B Biol Sci 351:191-199, 1996
6. Davies GF, Khandelwal RL, Roesler WJ: Troglitazone inhibits expression of the PEPCK gene by an insulin-independent mechanism. Biochim Biophys Acta 1451:122-131, 1999
7. Argaud D, Zhang Q, Pan W, Maitra S, Pilkis SJ, Lange AJ: Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states. Diabetes 45:1563-1571, 1996
8. Schmoll D, Allan BB, Burchell A: Cloning and sequencing of the 5′ region of the human glucose-6-phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells. FEBS Lett 383:63-66, 1996
9. Lin B, Morris DW, Chou JY: HNF1 alpha is an accessory factor required for activation of G6Pase gene transcription by glucocorticoids. DNA Cell Biol 17:967-974, 1998
10. Barzilai N, Rossetti L: Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 268:25019-25023, 1993
11. Valera A, Pujol A, Pelegrin M, Bosch F: Transgenic mice overexpressing PEPCK develop NIDDM. Proc Natl Acad Sci U S A 91:9151-9154, 1994
12. Rosella G, Zajac JD, Baker L, Kaczmarczyk SJ, Andrikopoulos S, Adams TE, Proietto J: Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive PEPCK gene. Mol Endocrinol 9:1396-1404, 1995
13. Massillon D, Barzilai N, Chen W, Hu M, Rossetti L: Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 271:9871-9874, 1996
14. Foster JD, Pederson BA, Nordlie RC: Glucose-6-phosphatase structure, regulation, and function: an update. Proc Soc Exp Biol Med 215:314-332, 1997
15. Trinh K, O'Doherty RM, Anderson P, Lange AJ, Newgard CB: Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615-31620, 1998
16. Lange AJ, Argaud D, el-Maghrabi MR, Pan W, Maitra SR, Pilkis SJ: Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. Biochem Biophys Res Commun 201:302-309, 1994
17. O'Brien RM, Printz RL, Halmi N, Tiesinga JJ, Granner DK: Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. Biochim Biophys Acta 1264:284-288, 1995
18. Hanson RW, Reshef L: Regulation of PEPCK gene expression. Annu Rev Biochem 66:581-611, 1997
19. Sutherland C, O'Brien RM, Granner DK: Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase gene expression by insulin. J Biol Chem 270:15501-15506, 1995
20. Gabbay RA, Sutherland C, Gnudi L, Kahn BB, O'Brien RM, Granner DK, Flier JS: Insulin regulation of PEPCK gene expression does not require activation of the Ras/MAP kinase signaling pathway. J Biol Chem 271:1890-1897, 1996
21. Kotani K, Ogawa W, Hino Y, Kitamura T, Sano W, Sutherland C, Granner DK, Kasuga M: Dominant-negative forms of Akt and atypical PKCλ do not prevent insulin inhibition of PEPCK gene transcription. J Biol Chem 274:21305-21312, 1999
22. O'Brien RM, Bonovich MT, Forest CD, Granner DK: Signal transduction convergence: phorbol esters and insulin inhibit PEPCK gene transcription through the same 10-base-pair sequence. Proc Natl Acad Sci U S A 88:6580-6584, 1991
23. Sutherland C, Tebbey PW, Granner DK: Oxidative and chemical stress mimic insulin by selectively inhibiting the expression of phosphoenolpyruvate carboxykinase in hepatoma cells. Diabetes 46:17-22, 1997
24. Dickens M, Svitek CA, Culbert AA, O'Brien RM, Tavare JM: Central role for PI 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin. J Biol Chem 273:20144-20149, 1998
25. Scott DK, O'Doherty RM, Stafford JM, Newgard CB, Granner DK: The repression of hormone-activated PEPCK gene expression by glucose is insulinindependent but requires glucose metabolism. J Biol Chem 273:24145-24151, 1998
26. Hardie DG, Carting D, Carlson M: The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821-855, 1998
27. Hardie DG, Salt IP, Hawley SA, Davies SP: AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338: 717-722, 1999
28. Winder WW, Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277:E1-E10, 1999
29. Corton JM, Gillespie JG, Hardie DG: Role of the AMP-activated protein kinase in the cellular stress response. Curr Biol 4:315-324, 1994
30. Winder WW, Hardie DG: Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 270:E299-E304, 1996
31. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD: High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270:17513-17520, 1995
32. Salt IP, Johnson G, Ashcroft SJH, Hardie DG: AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic β-cells, and may regulate insulin release. Biochem J 335:533-539, 1998
33. Corton JM, Gillespie JG, Hawley SA, Hardie DG: 5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558-565, 1995
34. Henin N, Vincent MF, Gruber HA, Van den Berghe G: Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J 9:541-546, 1995
35. Forest CD, O'Brien RM, Lucas PC, Magnuson MA, Granner DK: Regulation of PEPCK gene expression by insulin: use of the stable transfection approach to locate an insulin responsive sequence. Mol Endocrinol 4:1302-1310, 1990
36. Petersen DD, Magnuson MA, Granner DK: Location and characterization of two widely separated glucocorticoid response elements in the PEPCK gene. Mol Cell Biol 8:96-104, 1988
37. Mitchell J, Noisin E, Hall R, O'Brien R, Imai E, Granner D: Integration of multiple signals through a complex hormone response unit in the PEPCK gene promoter. Mol. Endocrinol 8:585-594, 1994
38. Davies SP, Carling D, Hardie DG: Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur J Biochem 186:123-128, 1989
39. Granner D, Andreone T, Sasaki K, Beale E: Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature 305:549-551, 1983
40. Wagle A, Jivraj S, Garlock GL, Stapleton SR: Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires PI 3-kinase. J Biol Chem 273:14968-14974, 1998
41. Woods A, Salt I, Scott J, Hardie DG, Carling D: The alphal and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397:347-351, 1996
42. Sutherland C, O'Brien R, Granner DK: Genetic regulation of glucose metabolism. In The Endocrine Pancreas and Regulation of Metabolism. Jefferson LS, Cherrington AD, Eds. New York, Oxford University Press. In press
43. Goswami R, Lacson R, Yang E, Sam R, Unterman T: Functional analysis of glucocorticoid and insulin response sequences in the rat IGFBP-1 promoter. Endocrinology 134:736-743, 1994
44. Suwanichkul A, Allander SV, Morris SL, Powell DR: Glucocorticoids and insulin regulate expression of the human gene for IGFBP-1 through proximal promoter elements. J Biol Chem 269:30835-30841, 1994
45. Grange T, Roux J, Rigaud G, Pictet R: Cell-type specific activity of two glucocorticoid responsive units of the rat TAT gene is associated with multiple binding sites for C/EBP and a novel liver-specific-nuclear factor. Nucleic Acids Res 19:131-139, 1991
46. Nitsch D, Boshart M, Schutz G: Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements. Proc Natl Acad Sci U S A 90:5479-5483, 1993
47. Chatelain F, Pegorier J, Minassian C, Bruni N, Tarpin S, Girard J, Mithieux G: Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes 47:882-889, 1998
48. Schmoll D, Watkins SL, Wasner C, Walther R, Burchell A: Glucose induces G6Pase hydrolytic subunit gene transcription in an insulinoma cell line (INS-1). FEBS Lett 443:53-56, 1999
49. Fujiwara T, Okuno A, Yoshioka S, Horikoshi H: Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL/KsJ-db/db mice. Metabolism 44:486-490, 1995
50. Kumar S, Boulton AJM, Beck-Nielson H, Berthezene F, Muggeo M, Persson B, Spinas GA, Donaghue S, Lettis S, Stewart-Long P: Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia 39:701-709, 1996
51. Witters LA, Kemp BE: Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5′-AMP-activated protein kinase. J Biol Chem 267:2864-2867, 1992
52. Gamble J, Lopaschuk GD: Insulin inhibition of 5′ adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism 46:1270-1274, 1998
53. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG: Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. Biol Chem 271:27879-27887, 1996
54. 2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270:27186-27191, 1995
55. Muoio DM, Seefeld K, Witters LA, Coleman RA: AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338:783-791, 1999
56. Sullivan JE, Brocklehurst KJ, Marley AE, Carey F, Carling D, Beri RK: Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AlCAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett 353:33-36, 1994
57. Merrill GM, Kurth EJ, Hardie DG, Winder WW: AICA riboside increases AMP-activated kinase, fatty acid oxidation and glucose uptake in rat muscle. Am J Physiol 273:E1107-E1112, 1997
58. Velasco G, Geelen MJH, Guzman M: Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys 337:169-175, 1997
59. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ: Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47:1369-1373, 1998
60. Bergeron R, Russell RR, Young LH, Ren JM, Marcucci M, Lee A, Shulman GI: Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 276:E938-E944, 1999
61. Russell RR, Bergeron R, Shulman GI, Young LH: Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277:H643-H649, 1999
62. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW: 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48:1667-1671, 1999
63. Leclere I, Kahn A, Doiron B: The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett 431:180-184, 1998
64. Foretz M, Carling D, Guichard C, Ferre P, Foufelle F: AMP-activatod protein kinase inhibits the glucose-activated expression of fatty acid synthase gene rat hepatocytes. J Biol Chem 273:14767-14771, 1998
65. Samari HR, Seglen PO: Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside: evidence for involvement of AMP-activated protein kinase. J Biol Chem 273:23758-23763, 1998
66. Stefanelli C, Stanic I, Bonavita F, Flamigni F, Pignatti C, Guarnieri G, Caldarera CM: Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase. Biochem Biophys Res Commun 243:821-826, 1998
67. Durante P, Geuning MA, Darville MI, Hue L, Rousseau GG: Apoptosis induced by growth factor withdrawal in fibroblasts overproducing fructose 2,6-bisphosphate. FEBS Lett 448:239-243, 1999
68. Smith FC, Davies SP, Wilson WA, Carling D, Hardie DG: The SNF1 kinase complex from Saccharomyces cerevisiae phosphorylates the transcriptional repressor protein Miglp in vitro at four sites within or near regulatory domain 1. FEBS Lett 453:219-223, 1999
69. Nehlin JO, Ronne H: Yeast MIG1 repressor is related to the mammalian early growth response and Wilms' tumour finger proteins. EMBO J 9:2891-2898, 1990
70. Vincent MF, Erion MD, Gruber HE, Van den Berghe G: Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 40:1259-1266, 1991
71. Vincent MF, Erion MD, Gruber HE, Van den Berghe G: Hypoglycaemic effect of AIC Ariboside in mice. Diabetologia 39:1148-1155, 1996